Equity Overview
Price & Market Data
Price: $5.18
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $224,161,392
Daily Volume: 0
Performance Metrics
1 Week: -13.23%
1 Month: -13.81%
3 Months: 24.82%
6 Months: 146.7%
1 Year: 270.0%
YTD: 28.86%
Company Details
Employees: 7
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the treatment of negative symptoms in patients with schizophrenia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.